BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics
01 September 2020
The BEAM Alliance and the co-signatories of this paper urge the EU and its Member States to urgently act and fix the broken economics around investment into the development and commercialization of antimicrobials.
Further reading: BEAM Alliance
Author(s): BEAM Alliance
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!
